| 产品描述: | 尼亚酰铵是基于吡啶的MAO(单胺氧化酶)酶的小分子非选择性抑制剂。作为一种非选择性抑制剂,尼亚酰铵e被描述为同时抑制MAO A和BAO。在研究中,尼亚酰铵已被用于介导喹啉酸诱导的海马损伤。;Nialamide is a pyridine-based small molecule non-selective inhibitor of MAO (monoamine oxidase) enzymes. As a non-selective inhibitor, Nialamide is described to inhibit both MAO A and B. Nialamide has been utilized to mediate quinolinic acid-induced hippocampal damage in studies. |
| 体内研究: |
Nialamide (100 mg/kg;皮下注射) 可增强雌性 NMRI 小鼠的运动亢进。 Nialamide (1-10 mg/kg;静脉注射) 可增强去甲肾上腺素在经 Reserpine 预处理的髓质猫中的升压作用。 Nialamide (100 mg/kg;腹腔注射) 可增强 Diphenylhydantoin 在小鼠体内的抗惊厥作用。 Nialamide (200 mg/kg;腹腔注射) 可诱导小鼠运动活动增加、直肠温度升高,并升高脑内 5-HT、NA 和多巴胺水平。 |
| 参考文献: |
1. Boldyrev AA, et al. Sources of reactive oxygen species production in excitotoxin- stimulated cerebellar granule cells. Biochem Biophys Res Commun. 1999 Mar 16;256(2):320-4. 2. Lee H, et al. Ionizing radiation induced modification of nialamide as an anti inflammatory agent against lipopolysaccharide induced RAW 264.7 and DH82 cells. Exp Ther Med. 2024 Mar 11;27(5):192. 3. Buus Lassen J. Nialamide-induced hypermotility in mice treated with inhibitors of monoamine uptake, 5-HT antagonists and lithium. Psychopharmacology (Berl). 1989;98(2):257-61. 4. DAVEY MJ, et al. The effects of nialamide on adrenergic functions. Br J Pharmacol Chemother. 1963 Feb;20(1):121-34. 5. P'AN SY, et al. Anticonvulsant effect of nialamide and diphenylhydantoin. Proc Soc Exp Biol Med. 1961 Dec;108:680-3. 6. Modigh K, et al. On the role of central nervous system catecholamines and 5-hydroxytryptamine in the nialamide-induced behavioural syndrome. Br J Pharmacol. 1972 Sep;46(1):32-45. |
| 保存条件: |
-80℃(运输条件:冰袋低温运输) |
| 配置溶液浓度参考: |
|
1mg |
5mg |
10mg |
| 1 mM |
3.352 ml |
16.759 ml |
33.519 ml |
| 5 mM |
0.67 ml |
3.352 ml |
6.704 ml |
| 10 mM |
0.335 ml |
1.676 ml |
3.352 ml |
| 50 mM |
0.067 ml |
0.335 ml |
0.67 ml |
|
| 注意: |
部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。 |